icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research icrowd research

Artesunate Tablet Market Size Expected to Reach USD $190 Million with CAGR of 6% by 2030 – IndustryAR

Oct 10, 2023 2:00 AM ET

Artesunate Tablet Market Size Expected to Reach USD $190 Million with CAGR of 6% by 2030 – IndustryAR

Artesunate Tablet Market focuses on Artesunate tablets are essential in treating malaria, effectively targeting the malarial parasite. They may cause common side effects like headaches, dizziness, and nausea. Despite potential side effects, Artesunate remains a crucial weapon in the fight against malaria.

The global Artesunate Tablet Market size was valued at USD $190 Million in 2030, and it is expected to reach, growing at a compound annual growth rate (CAGR) of 6% from 2023 to 2030.

The Artesunate tablet market has witnessed substantial growth and evolution in recent years, driven by several key factors, including rising incidences of malaria, increasing awareness about the efficacy of Artesunate as an anti-malarial drug, and the expansion of healthcare infrastructure in developing regions.

Artesunate, derived from the sweet wormwood plant, Artemisia annua, has become a vital component in the global effort to combat malaria, a life-threatening disease caused by the Plasmodium parasite.

Artesunate is one of several drugs used to treat malaria. Its effectiveness and availability can impact its market share compared to other anti-malarial drugs like chloroquine or quinine.

The development of resistance to other antimalarial drugs, such as chloroquine and sulfadoxine-pyrimethamine, has increased the demand for Artesunate and combination therapies as they have shown greater efficacy against resistant strains.

Efforts by organizations like the World Health Organization (WHO) and various governments to combat malaria through distribution programs and financial support have contributed to the growth of the Artesunate tablet market

Competition among pharmaceutical companies in the antimalarial drug market can influence pricing and availability of Artesunate tablets. Healthy competition can benefit consumers by improving access and affordability.

The Artesunate tablet market may experience growth due to an increase in malaria cases, expanding healthcare access, and rising awareness of malaria prevention and treatment.

Artesunate Tablet Market Current and Future Trends

The market for Artesunate tablets is driven by the rising prevalence of malaria, especially in sub-Saharan Africa and Southeast Asia. The World Health Organization (WHO) has recommended the use of Artesunate as the first-line treatment for severe malaria, further propelling the market growth. Additionally, various initiatives by governments and non-profit organizations to combat malaria have increased the availability and accessibility of Artesunate tablets in these regions.

Development of New Formulations: Pharmaceutical companies may continue to invest in research and development to create more effective and convenient formulations of Artesunate tablets. This could include extended-release versions, pediatric formulations, or combinations with other antimalarial drugs.

 Resistance Mitigation Strategies: Efforts to combat drug resistance in malaria treatment are likely to continue. New drug combinations and treatment strategies may be developed to address emerging resistance issues, ensuring the continued efficacy of Artesunate.

 Access and Distribution: Initiatives to improve access to Artesunate and other antimalarial drugs in underserved regions may expand. This could involve partnerships between governments, NGOs, and pharmaceutical companies to enhance distribution networks and reduce costs.

 Global Health Partnerships: Collaborative efforts between global health organizations, governments, and pharmaceutical companies may intensify to combat malaria. These partnerships can lead to increased funding for research, development, and distribution of antimalarial treatments.

Browse Table of Contents of the Full Report:

Artesunate Tablet Market Report – Scope:

The Artesunate Tablet Market has been segmented by Type, Applications and geography. The report provides insights into the market dynamics, including market drivers and challenges.

Artesunate Tablet Market Report analyzes market trends, key players, and growth opportunities in the Artesunate Tablet sector.

The competitive landscape section features company profiles of major players such as Cipla Sanofi and Guilin Pharmaceutical. This report is a valuable source of guidance and direction for companies and individuals interested in the market.

Request a sample for the report:

The top 10 players in the Artesunate Tablet Industry are:

  1. Fosun Pharma 
  2. Ipca Laboratories 
  3. Sanofi Aventis 
  4. Ajanta Pharma
  5. Shin Poong 
  6. Cipla 
  7. Acino 
  8. MCW Healthcare 
  9. Aurobindo Pharma 
  10. Torrent Pharmaceuticals 

Please verify this information with the latest sources, as the pharmaceutical industry is subject to ongoing changes and developments.

Follow the Link to Buy the latest Market Study on Artesunate Tablet:

Browse More Trending Reports related to Glass Industry By IndustryARC. The global artesunate tablet market size was USD 118 million in 2022 and market is projected to touch USD 190 million by 2030, exhibiting a compound annual growth rate (CAGR) of 6.0% during the forecast period.

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website, but also get personalized assistance on specific reports.

Contact Us:

Mr. Venkat Reddy


Email: [email protected]

USA: (+1) 518-282-4727


Follow us on: LinkedIn | Facebook | Twitter


Tags: , , , , , ,

See Campaign:

Contact Information:

Mr. Venkat Reddy IndustryARC Email: [email protected] USA: (+1) 518-282-4727


Extended Distribution, BNN, iCN Internal Distribution, Research Newswire, English